Denintuzumab mafodotin (SGN-CD19A)
Revision as of 17:15, 25 July 2017 by Warner-admin (talk | contribs) (Text replacement - "Category:Intravenous chemotherapy" to "Category:Intravenous medications")
Mechanism of action
Antibody-drug conjugate
Preliminary studies
- Abstract: Andres Forero-Torres, Craig Moskowitz, Ranjana H. Advani, Bijal D. Shah, Ana Kostic, Tina M. Albertson, Larissa Sandalic, Baiteng Zhao, Michelle A. Fanale. Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL). J Clin Oncol 32:5s, 2014 (suppl; abstr 8505) link to original abstract